Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 351

1.

Serum anti-Müllerian hormone and inhibin B concentrations are not useful predictors of ovarian response during ovulation induction treatment with recombinant follicle-stimulating hormone in women with polycystic ovary syndrome.

Lie Fong S, Schipper I, de Jong FH, Themmen AP, Visser JA, Laven JS.

Fertil Steril. 2011 Aug;96(2):459-63. doi: 10.1016/j.fertnstert.2011.05.084. Epub 2011 Jun 29.

PMID:
21719005
2.

Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.

Anderson RA, Groome NP, Baird DT.

Clin Endocrinol (Oxf). 1998 May;48(5):577-84.

PMID:
9666869
3.

Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.

Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.

Fertil Steril. 2008 Apr;89(4):860-7. doi: 10.1016/j.fertnstert.2007.04.010. Epub 2008 Feb 4.

PMID:
18249372
4.

The influence of circulating anti-Müllerian hormone on ovarian responsiveness to ovulation induction with gonadotrophins in women with polycystic ovarian syndrome: a pilot study.

Amer SA, Mahran A, Abdelmaged A, El-Adawy AR, Eissa MK, Shaw RW.

Reprod Biol Endocrinol. 2013 Dec 17;11:115. doi: 10.1186/1477-7827-11-115.

5.

Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.

Piltonen T, Morin-Papunen L, Koivunen R, Perheentupa A, Ruokonen A, Tapanainen JS.

Hum Reprod. 2005 Jul;20(7):1820-6. Epub 2005 Mar 31.

6.

Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.

Wunder DM, Guibourdenche J, Birkhäuser MH, Bersinger NA.

Fertil Steril. 2008 Dec;90(6):2203-10. doi: 10.1016/j.fertnstert.2007.10.078. Epub 2008 Feb 21.

PMID:
18291376
7.

Anti-Müllerian hormone and antral follicle count for prediction of ovarian stimulation response in polycystic ovary syndrome.

El-Mazny A, Abou-Salem N.

Gynecol Endocrinol. 2013 Sep;29(9):826-9. doi: 10.3109/09513590.2013.813466. Epub 2013 Jul 15.

PMID:
23855354
8.

Anti-Mullerian hormone is a better marker than inhibin B, follicle stimulating hormone, estradiol or antral follicle count in predicting the outcome of in vitro fertilization.

Kunt C, Ozaksit G, Keskin Kurt R, Cakir Gungor AN, Kanat-Pektas M, Kilic S, Dede A.

Arch Gynecol Obstet. 2011 Jun;283(6):1415-21. doi: 10.1007/s00404-011-1889-7. Epub 2011 Mar 29.

PMID:
21562964
9.
10.

The predictive value of circulating anti-Müllerian hormone in women with polycystic ovarian syndrome receiving clomiphene citrate: a prospective observational study.

Mahran A, Abdelmeged A, El-Adawy AR, Eissa MK, Shaw RW, Amer SA.

J Clin Endocrinol Metab. 2013 Oct;98(10):4170-5. doi: 10.1210/jc.2013-2193. Epub 2013 Aug 26.

PMID:
23979947
11.

Clinical significance of serum concentration of anti-Müllerian hormone in obese women with polycystic ovary syndrome.

El-Halawaty S, Rizk A, Kamal M, Aboulhassan M, Al-Sawah H, Noah O, Al-Inany H.

Reprod Biomed Online. 2007 Nov;15(5):495-9.

PMID:
18028738
13.

The relationship between serum anti-Müllerian hormone levels and the follicular arrest for women with polycystic ovary syndrome.

Li J, Li R, Yu H, Zhao S, Yu Y, Qiao J.

Syst Biol Reprod Med. 2015 Apr;61(2):103-9. doi: 10.3109/19396368.2014.973123. Epub 2014 Oct 20.

PMID:
25329139
14.

[Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].

Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.

Akush Ginekol (Sofiia). 2013;52 Suppl 1:16-23. Bulgarian.

PMID:
24294740
16.

Ovarian reserve in women with polycystic ovary syndrome who underwent laparoscopic ovarian drilling.

Weerakiet S, Lertvikool S, Tingthanatikul Y, Wansumrith S, Leelaphiwat S, Jultanmas R.

Gynecol Endocrinol. 2007;23(8):455-60.

PMID:
17852413
17.

Relationship between 17-hydroxyprogesterone responses to human chorionic gonadotropin and markers of ovarian follicle morphology in women with polycystic ovary syndrome.

Maas KH, Chuan SS, Cook-Andersen H, Su HI, Duleba A, Chang RJ.

J Clin Endocrinol Metab. 2015 Jan;100(1):293-300. doi: 10.1210/jc.2014-2956.

18.

Changes in serum anti-mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome.

Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D.

J Clin Endocrinol Metab. 2007 Nov;92(11):4138-43. Epub 2007 Aug 14.

PMID:
17698904
19.
20.
Items per page

Supplemental Content

Write to the Help Desk